Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga August 21, 2014 at 08:14 AM EDT Kindred Biosciences (NASDAQ: KIN) fell 30.68% to $9.85 in pre-market trading after the company reported that its pivotal field study ... Read More >> Related Stocks: China Finance Online ADR Kindred Biosciences Stage Stores